关注
Stephan Holger Drukewitz
Stephan Holger Drukewitz
在 uni-leipzig.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Convergent evolution of the ladder-like ventral nerve cord in Annelida
C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ...
Frontiers in zoology 15, 1-17, 2018
682018
A dipteran’s novel sucker punch: Evolution of arthropod atypical venom with a neurotoxic component in robber flies (Asilidae, Diptera)
SH Drukewitz, N Fuhrmann, EAB Undheim, A Blanke, J Giribaldi, R Mary, ...
Toxins 10 (1), 29, 2018
422018
The significance of comparative genomics in modern evolutionary venomics
SH Drukewitz, BRM Von Reumont
Frontiers in Ecology and Evolution 7, 163, 2019
382019
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ...
Annals of Oncology 33 (11), 1186-1199, 2022
302022
Toxins from scratch? Diverse, multimodal gene origins in the predatory robber fly Dasypogon diadema indicate a dynamic venom evolution in dipteran insects
SH Drukewitz, L Bokelmann, EAB Undheim, BM von Reumont
GigaScience 8 (7), giz081, 2019
282019
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
A Hennig, F Baenke, A Klimova, S Drukewitz, B Jahnke, S Brückmann, ...
The Journal of pathology 257 (5), 607-619, 2022
242022
Comparative analyses of glycerotoxin expression unveil a novel structural organization of the bloodworm venom system
S Richter, C Helm, FA Meunier, L Hering, LI Campbell, SH Drukewitz, ...
BMC Evolutionary Biology 17, 1-19, 2017
222017
Decoding single cell morphology in osteotropic breast cancer cells for dissecting their migratory, molecular and biophysical heterogeneity
L Bemmerlein, IA Deniz, J Karbanova, A Jacobi, S Drukewitz, T Link, ...
Cancers 14 (3), 603, 2022
132022
Combined systemic drug treatment with proton therapy: Investigations on patient-derived organoids
M Naumann, T Czempiel, AJ Lößner, K Pape, E Beyreuther, S Löck, ...
Cancers 14 (15), 3781, 2022
82022
Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models
M Ullrich, S Richter, J Liers, S Drukewitz, M Friedemann, J Kotzerke, ...
Theranostics 13 (1), 278, 2023
72023
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
T Schmäche, J Fohgrub, A Klimova, K Laaber, S Drukewitz, F Merboth, ...
Molecular Cancer 23 (1), 10, 2024
42024
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
AA Wurm, S Brilloff, S Kolovich, S Schäfer, E Rahimian, V Kufrin, M Bill, ...
Cell Reports Medicine 4 (10), 2023
42023
Treatment of pheochromocytoma cells with recurrent cycles of hypoxia: a new pseudohypoxic In vitro model
J Helm, S Drukewitz, I Poser, S Richter, M Friedemann, D William, H Mohr, ...
Cells 11 (3), 560, 2022
42022
Clinical impact of polygenic risk score for breast cancer risk prediction in 382 individuals with hereditary breast and ovarian cancer syndrome
S Stiller, S Drukewitz, K Lehmann, J Hentschel, V Strehlow
Cancers 15 (15), 3938, 2023
32023
Chronic ER stress promotes cGAS/mtDNA-induced autoimmunity via ATF6 in myotonic dystrophy type 2
C Günther, S Rösing, F Ullrich, S Meisterfeld, F Schmidt, N Eberl, ...
22022
Breaking the ladder: Evolution of the ventral nerve cord in Annelida
C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ...
BioRxiv, 378661, 2018
22018
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release
S Rösing, F Ullrich, S Meisterfeld, F Schmidt, L Mlitzko, M Croon, ...
Nature Communications 15 (1), 1534, 2024
12024
Case report: Complete paternal isodisomy on chromosome 18 induces methylation changes in PARD6G-AS1 promotor in a case with arthrogryposis
J Moch, M Radtke, J Gburek-Augustat, M Karnstedt, S Schönnagel, ...
Frontiers in Genetics 14, 1297754, 2023
12023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas
M Li, S Richter, H Mohr, S Drukewitz, I Poser, D Stanke, B Calsina, ...
Endocrine-related cancer 30 (12), 2023
12023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer
DM Klotz, FM Schwarz, A Dubrovska, K Schuster, M Theis, A Krüger, ...
Cancers 15 (15), 3774, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20